| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |